ConductScience.org, home

Paper22010102

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Jagasia M and 21 others. Blood, 2012. Cited by 573 papers, by iCite.

Cite this record

ConductScience Library. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Papers, record 22010102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22010102

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
PubMed
Journal
Blood
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
573
iCite
Relative citation ratio, by iCite
17
iCite
Revised in PubMed
2022-04-08
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jagasia MMadan
2Arora MMukta
3Flowers MEMary E D
4Chao NJNelson J
5McCarthy PLPhilip L
6Cutler CSCorey S
7Urbano-Ispizua AAlvaro
8Pavletic SZSteven Z
9Haagenson MDMichael D
10Zhang MJMei-Jie
11Antin JHJoseph H
12Bolwell BJBrian J
13Bredeson CChristopher
14Cahn JYJean-Yves
15Cairo MMitchell
16Gale RPRobert Peter
17Gupta VVikas
18Lee SJStephanie J
19Litzow MMark
20Weisdorf DJDaniel J

Source PubMed

See all 22 authorsDownload CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft vs Host DiseaseMajor topic
Hematologic NeoplasmsMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Whole-Body IrradiationMajor topic
Acute Disease
Adolescent
Adult
Aged
Child
Child, Preschool
Female
Histocompatibility
Humans
Infant
Male
Middle Aged
Retrospective Studies
Risk Factors
Siblings
Survival Rate
Tissue Donors
Transplantation Conditioning
Transplantation, Homologous
Unrelated Donors
Young Adult

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5U01HL069294NHLBI NIH HHSUnited StatesU01HL069294PubMed and NIHNIH RePORTER
U24 CA076518NCI NIH HHSUnited StatesU24CA076518PubMed and NIHNIH RePORTER
U24-CA76518NCI NIH HHSUnited StatesU24CA076518PubMed and NIHNIH RePORTER
U01 HL069294NHLBI NIH HHSUnited StatesU01HL069294PubMed and NIHNIH RePORTER
P01 CA047741NCI NIH HHSUnited StatesP01CA047741PubMed and NIHNIH RePORTER
HHSH234200637015CPHS HHSUnited StatesPubMedPubMed

Download CSV of grants

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05350163T-cell Receptor α/β Depleted Donor Lymphocyte InfusionBackgroundClinicalTrials.gov
NCT06840756Effects of Donor-recipient Sex-matched Blood Transfusion on Patient OutcomesBackgroundClinicalTrials.gov
NCT07576699CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)BackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in22223818The Serenity Prayer for acute GVHD.https://conductscience.org/library/papers/22223818

Source PubMed

Download CSV of comments and corrections

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119714314Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells.Mol Cells2009https://conductscience.org/library/papers/19714314PubMed
27670393Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation.Bone Marrow Transplant1995https://conductscience.org/library/papers/7670393PubMed
310204198Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.Stat Med1999https://conductscience.org/library/papers/10204198PubMed
417025025Acute graft-versus-host disease. The incidence and risk factors.Ann Transplant2006https://conductscience.org/library/papers/17025025PubMed
59217189IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.Br J Haematol1997https://conductscience.org/library/papers/9217189PubMed
617348080Analyzing survival curves at a fixed point in time.Stat Med2007https://conductscience.org/library/papers/17348080PubMed
714993883Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.Biol Blood Marrow Transplant2004https://conductscience.org/library/papers/14993883PubMed
816946302
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Blood2006https://conductscience.org/library/papers/16946302PubMed
93288872Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.N Engl J Med1988https://conductscience.org/library/papers/3288872PubMed
1015113759
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood2004https://conductscience.org/library/papers/15113759PubMed
116337323Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.N Engl J Med1983https://conductscience.org/library/papers/6337323PubMed
1212203168Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors.Clin Infect Dis2002https://conductscience.org/library/papers/12203168PubMed
1312663454Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.Blood2003https://conductscience.org/library/papers/12663454PubMed
142249952Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.Hum Immunol1990https://conductscience.org/library/papers/2249952PubMed
1519203728Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.Biol Blood Marrow Transplant2009https://conductscience.org/library/papers/19203728PubMed
1616210336Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.Blood2006https://conductscience.org/library/papers/16210336PubMed
172164434
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Bone Marrow Transplant1990https://conductscience.org/library/papers/2164434PubMed
189894716A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies.Bone Marrow Transplant1998https://conductscience.org/library/papers/9894716PubMed
1910197799Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.Bone Marrow Transplant1999https://conductscience.org/library/papers/10197799PubMed
2019224849HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.J Clin Oncol2009https://conductscience.org/library/papers/19224849PubMed

See all 42 referencesDownload CSV of references

Cited by368

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 573 citations.

PMIDTitleJournalYearIn PapersSource
42851397Time-adjusted direct medical costs of moderate-to-severe chronic graft-versus-host disease: a retrospective two-center cost analysis in Türkiye.Front Public Health2026https://conductscience.org/library/papers/42851397PubMed
42844290Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.Bone Marrow Transplant2026https://conductscience.org/library/papers/42844290PubMed
42782891Idiopathic Pneumonia Syndrome and Pulmonary Toxicity After Total Body Irradiation for Bone Marrow Transplantation in the Modern Transplant Era.Curr Oncol2026https://conductscience.org/library/papers/42782891PubMed
42754641GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis.Bone Marrow Transplant2026https://conductscience.org/library/papers/42754641PubMed
42734876Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.BioDrugs2026https://conductscience.org/library/papers/42734876PubMed
42676515Early and sex-specific dynamic changes of the modified Glasgow Prognostic Score correlate with survival and immunotoxicities in patients undergoing allogeneic hematopoietic stem cell transplantation.Front Immunol2026https://conductscience.org/library/papers/42676515PubMed
42671266HLA-A ∗01:01 Allele Is Associated With Increased Risk of Transplant-Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation.J Immunol Res2026https://conductscience.org/library/papers/42671266PubMed
42612728Outcomes After Matched Sibling Donor Versus Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.Transplant Cell Ther2026https://conductscience.org/library/papers/42612728PubMed
42533070The real-world safety of ruxolitinib in graft-versus-host disease treatment: a pharmacovigilance study based on the FDA adverse event reporting system.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42533070PubMed
42367753Advances in graft-versus-host disease: emerging therapeutic strategies, biomarker discoveries, and innovative treatment approaches.Front Immunol2026https://conductscience.org/library/papers/42367753PubMed
42215807Cyclosporine in hematological disorders: mechanisms, clinical practice and emerging advances.Ann Hematol2026https://conductscience.org/library/papers/42215807PubMed
41986581Impact of lymphocyte p-glycoprotein activity on development of graft-versus-host disease after stem cell transplantation.Int J Hematol2026https://conductscience.org/library/papers/41986581PubMed
41904242Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.Bone Marrow Transplant2026https://conductscience.org/library/papers/41904242PubMed
41787572The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials.Stem Cell Res Ther2026https://conductscience.org/library/papers/41787572PubMed
41686349Recent advances in the pathophysiology of acute and chronic graft-versus-host disease.Int J Hematol2026https://conductscience.org/library/papers/41686349PubMed
41681858The Effect of Post-Transplant Cyclophosphamide Administration on Graft-Versus-Host Disease in Allogeneic Bone Marrow Transplantation.Cancers (Basel)2026https://conductscience.org/library/papers/41681858PubMed
41643175Differential effects of GVHD therapies on intestinal epithelium.Blood Adv2026https://conductscience.org/library/papers/41643175PubMed
41611709Circadian fluctuation of soluble CD26 dictates the impact of the timing of cord blood transplantation on acute graft-versus-host disease.Nat Commun2026https://conductscience.org/library/papers/41611709PubMed
41498421Validated clinical risk score for acute graft-versus-host disease in adult allogeneic hematopoietic cell transplantation.Blood Adv2026https://conductscience.org/library/papers/41498421PubMed
41413745Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation.Eur J Clin Pharmacol2025https://conductscience.org/library/papers/41413745PubMed

See all 368 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22010102

GET https://conductscience.org/api/papers/v1/22010102/authors?page=2